Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning.

Maria Giovanna MoscaMaria ManginiStefania CioffiPasquale BarbaStefania Mariggiò

Published in: Cell communication and signaling : CCS (2021)

Our data indicate that GPR55 represents a target for development of novel therapeutic approaches for treatment of pathological conditions caused by osteoclast-exacerbated bone degradation, such as in osteoporosis or during establishment of bone metastases. Video abstract.

Keyphrases

bone loss
bone mineral density
fatty acid
postmenopausal women
electronic health record
cancer therapy
big data
combination therapy
machine learning
body composition
lps induced
soft tissue
replacement therapy
bone regeneration